The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1-(6-(8-Fluoronaphthalen-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)-2-methylpropyl)-1-methylimidazolidine-2,4-dione ID: ALA4755933
PubChem CID: 137477755
Max Phase: Preclinical
Molecular Formula: C23H22FN3O3
Molecular Weight: 407.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C(c1ccc(-c2ccc3cccc(F)c3c2)[nH]c1=O)C1C(=O)NC(=O)N1C
Standard InChI: InChI=1S/C23H22FN3O3/c1-12(2)19(20-22(29)26-23(30)27(20)3)15-9-10-18(25-21(15)28)14-8-7-13-5-4-6-17(24)16(13)11-14/h4-12,19-20H,1-3H3,(H,25,28)(H,26,29,30)
Standard InChI Key: OXVFJOAEQVCXLP-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
23.3065 -20.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3065 -21.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0117 -21.6927 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7170 -21.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7170 -20.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0117 -20.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5954 -20.0659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5993 -21.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4223 -21.6968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4198 -22.5151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1261 -22.9246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1270 -21.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8339 -21.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8327 -22.5163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5417 -22.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2525 -22.5160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2497 -21.6922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5401 -21.2862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8901 -20.4785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1801 -20.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8947 -21.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5378 -20.4690 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.5900 -19.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2484 -18.7606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9915 -17.9848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1742 -17.9894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9262 -18.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1505 -19.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.4681 -17.3210 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0270 -19.0087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
1 7 1 0
2 8 2 0
9 10 2 0
10 11 1 0
11 14 2 0
13 12 2 0
12 9 1 0
4 9 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
7 19 1 0
19 20 1 0
19 21 1 0
18 22 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
7 23 1 0
27 28 2 0
25 29 2 0
24 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.45Molecular Weight (Monoisotopic): 407.1645AlogP: 3.62#Rotatable Bonds: 4Polar Surface Area: 82.27Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.89CX Basic pKa: ┄CX LogP: 2.45CX LogD: 2.44Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -0.65
References 1. Zhang X,Zhu B,Guo L,Bakaj I,Rankin M,Ho G,Kauffman J,Lee SP,Norquay L,Macielag MJ. (2021) Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes., 12 (3): [PMID:33738072 ] [10.1021/acsmedchemlett.0c00667 ]